tradingkey.logo
tradingkey.logo
Search

Olema Pharmaceuticals Inc

OLMA
Add to Watchlist
11.450USD
-0.370-3.13%
Close 07-31 16:00ETQuotes delayed by 15 min
1.00BMarket Cap
LossP/E TTM

OLMA Financials

See Olema Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Olema Pharmaceuticals Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.52/-0.53
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.87
15.29%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-45.17%-0.52
-13.23%-0.50
18.40%-0.49
5.13%-0.51
36.17%-0.36
8.55%-0.45
-26.23%-0.60
-9.39%-0.54
20.50%-0.56
25.25%-0.49
---0.48
---0.49
---0.70
---0.65
---1.97
----
----
----
----
----
Net Profit
-74.70%-53.09M
-37.22%-46.06M
-22.17%-42.22M
-44.11%-43.78M
1.88%-30.39M
-25.38%-33.57M
-60.71%-34.55M
-51.19%-30.38M
-9.49%-30.97M
-2.27%-26.77M
5.36%-21.50M
38.84%-20.09M
-22.82%-28.29M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
-113.58%-21.64M
---17.71M
-568.81%-16.41M
Debt to assets ratio
--0.57%
--0.56%
--0.85%
--0.79%
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
----
----
Operating profit
-66.28%-57.99M
-36.22%-50.08M
-21.95%-45.88M
-42.75%-47.86M
-1.56%-34.87M
-20.88%-36.77M
-61.17%-37.62M
-55.22%-33.53M
-16.00%-34.34M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.60M
-27.30%-29.60M
-25.10%-27.22M
-30.74%-23.22M
-101.51%-33.29M
-50.51%-23.25M
-114.76%-21.76M
---17.76M
-564.60%-16.52M
Net Profit
-74.70%-53.09M
-37.22%-46.06M
-22.17%-42.22M
-44.11%-43.78M
1.88%-30.39M
-25.38%-33.57M
-60.71%-34.55M
-51.19%-30.38M
-9.49%-30.97M
-2.27%-26.77M
5.36%-21.50M
38.84%-20.09M
-22.82%-28.29M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
-113.58%-21.64M
---17.71M
-568.81%-16.41M
Current assets
29.39%513.23M
17.56%515.45M
53.37%334.33M
51.84%367.73M
57.35%396.66M
64.52%438.47M
-22.70%217.99M
41.21%242.19M
33.10%252.09M
27.58%266.51M
25.30%282.01M
-29.43%171.51M
-29.91%189.40M
-28.14%208.90M
-27.00%225.06M
-24.26%243.03M
-18.18%270.21M
-15.04%290.69M
138.82%308.28M
--320.85M
Total current liabilities
80.97%47.17M
24.05%51.80M
35.68%41.66M
24.98%33.16M
-0.61%26.06M
93.14%41.76M
92.28%30.70M
78.92%26.54M
35.11%26.22M
30.65%21.62M
27.20%15.97M
20.50%14.83M
90.89%19.41M
83.49%16.55M
41.02%12.55M
51.09%12.31M
92.69%10.17M
96.71%9.02M
68.80%8.90M
--8.15M
Total assets
29.54%530.64M
18.28%533.43M
53.13%352.45M
50.07%382.00M
55.35%409.64M
62.84%450.98M
-21.39%230.17M
43.31%254.56M
34.70%263.69M
28.43%276.94M
26.21%292.80M
-29.12%177.62M
-29.43%195.77M
-27.13%215.65M
-25.11%232.00M
-22.23%250.60M
-16.26%277.42M
-13.65%295.94M
137.06%309.80M
--322.23M
Total liabilities
91.57%50.17M
30.60%54.87M
43.83%44.97M
34.21%36.77M
-4.34%26.19M
82.28%42.02M
76.97%31.26M
70.77%27.39M
31.66%27.38M
27.36%23.05M
23.55%17.66M
12.04%16.04M
68.66%20.79M
59.08%18.10M
60.63%14.30M
75.75%14.32M
133.62%12.33M
148.14%11.38M
68.80%8.90M
--8.15M
Total equity
25.30%480.48M
17.02%478.56M
54.59%307.49M
51.98%345.24M
62.26%383.45M
61.08%408.96M
-27.70%198.91M
40.59%227.16M
35.06%236.32M
28.52%253.90M
26.38%275.13M
-31.61%161.58M
-33.99%174.97M
-30.58%197.55M
-27.65%217.70M
-24.77%236.28M
-18.69%265.09M
-15.84%284.57M
139.93%300.89M
--314.08M
Net operating income
-4.57%-45.99M
-45.82%-38.33M
-27.80%-34.53M
-8.45%-29.88M
-87.18%-43.98M
-42.26%-26.28M
-18.78%-27.02M
-24.59%-27.55M
-15.23%-23.50M
6.27%-18.48M
-26.41%-22.74M
16.41%-22.12M
-13.90%-20.39M
-5.96%-19.71M
-48.72%-17.99M
-197.13%-26.46M
-61.52%-17.90M
-106.40%-18.60M
---12.10M
-654.02%-8.90M
Net investment
110.05%4.53M
-41.74%-162.18M
-62.38%17.27M
801.80%34.23M
-123.80%-45.08M
-270.12%-114.42M
280.53%45.92M
-134.56%-4.88M
-153.88%-20.14M
-289.24%-30.91M
-226.15%-25.44M
-52.02%14.11M
46.23%37.39M
172.27%16.34M
257.73%20.16M
169.09%29.41M
109.14%25.57M
11864.71%6.00M
---12.78M
182266.67%10.93M
Net financing
20487.39%45.70M
-12.59%213.55M
-55.43%41.00K
-116.14%-2.52M
-97.48%222.00K
46611.28%244.30M
-99.93%92.00K
663.83%15.61M
3909.55%8.82M
91.58%523.00K
123134.91%130.63M
3092.19%2.04M
566.67%220.00K
-66.63%273.00K
85.96%106.00K
-87.60%64.00K
--33.00K
-99.63%818.00K
--57.00K
-97.83%516.00K

FAQs

What are the current assets of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its current assets were 515.45M, with a year-on-year change of 17.56.

What are the total assets of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its total assets of Olema Pharmaceuticals Inc were 533.43M, with a year-on-year change of 18.28.

What are the total liabilities of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Olema Pharmaceuticals Inc were 54.87M, with a year-on-year change of 30.60.

What is the total equity of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its total equity of Olema Pharmaceuticals Inc was 478.56M, with a year-on-year change of 17.02.

What is the net operating income of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Olema Pharmaceuticals Inc was -178.70M, with a year-on-year change of -25.62.

What is the net investment of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its net investment of Olema Pharmaceuticals Inc was -155.76M, with a year-on-year change of -66.54.

What is the net financing of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its net financing of Olema Pharmaceuticals Inc was 211.30M, with a year-on-year change of -21.40.

What is the Earnings Per Share (EPS) of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.87, with a year-on-year change of 15.29.

What is the net income of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its net income was -162.45M, with a year-on-year change of -25.47.

What is the Return on Equity (ROE) of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -36.61, with a year-on-year change of 6.29.

What is the Return on Assets (ROA) of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -33.00, with a year-on-year change of 7.22.

What is the operating profit of Olema Pharmaceuticals Inc?

According to Olema Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -178.70M, with a year-on-year change of -25.62.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.